Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (390)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1109
6.310
 Why?
Antirheumatic Agents
24
2024
282
5.810
 Why?
Veterans
32
2023
1419
4.170
 Why?
Spondylitis, Ankylosing
5
2020
46
2.530
 Why?
Hyperkalemia
3
2023
26
2.410
 Why?
Veterans Health
8
2023
175
2.240
 Why?
United States Department of Veterans Affairs
12
2021
637
2.040
 Why?
Methotrexate
10
2021
250
1.900
 Why?
Medication Adherence
7
2019
569
1.440
 Why?
Spondylarthritis
3
2020
45
1.340
 Why?
Natural Language Processing
4
2023
94
1.310
 Why?
Registries
18
2024
1884
1.300
 Why?
Rheumatology
2
2020
111
1.260
 Why?
Biological Products
6
2021
200
1.240
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
256
1.230
 Why?
Tumor Necrosis Factor-alpha
6
2024
1192
1.150
 Why?
Drug Substitution
3
2021
52
0.990
 Why?
Psoriasis
2
2015
92
0.910
 Why?
Aged
46
2024
22090
0.900
 Why?
Arthritis, Psoriatic
3
2019
20
0.860
 Why?
Lymphoma, Follicular
2
2021
38
0.860
 Why?
Sulfasalazine
3
2019
23
0.830
 Why?
Hydroxychloroquine
3
2019
55
0.810
 Why?
Misoprostol
1
2022
17
0.790
 Why?
HLA-B27 Antigen
3
2019
15
0.780
 Why?
Middle Aged
47
2024
31080
0.780
 Why?
Lung Diseases, Interstitial
6
2024
597
0.770
 Why?
Humans
96
2024
129128
0.770
 Why?
United States
31
2023
13940
0.740
 Why?
Databases, Factual
7
2018
1279
0.740
 Why?
Electronic Health Records
6
2023
976
0.730
 Why?
Cohort Studies
16
2024
5407
0.710
 Why?
Rituximab
2
2021
163
0.690
 Why?
Infliximab
3
2016
100
0.690
 Why?
Analgesics, Opioid
5
2020
908
0.690
 Why?
Practice Patterns, Physicians'
5
2019
1270
0.680
 Why?
Insurance Claim Review
2
2017
72
0.660
 Why?
Pharmaceutical Services
2
2019
83
0.650
 Why?
Buprenorphine
1
2023
165
0.640
 Why?
Algorithms
5
2020
1621
0.640
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
45
0.640
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
343
0.630
 Why?
Treatment Outcome
19
2024
10227
0.630
 Why?
Male
54
2024
63202
0.620
 Why?
Arthritis
2
2021
114
0.610
 Why?
Datasets as Topic
1
2019
110
0.610
 Why?
Anemia, Iron-Deficiency
1
2019
58
0.600
 Why?
Severity of Illness Index
12
2023
2739
0.600
 Why?
Antineoplastic Agents, Immunological
1
2020
174
0.600
 Why?
Etanercept
2
2016
58
0.590
 Why?
Adalimumab
2
2016
44
0.590
 Why?
Iron
2
2021
283
0.590
 Why?
Kidney Failure, Chronic
1
2022
535
0.550
 Why?
Renal Insufficiency, Chronic
2
2021
566
0.530
 Why?
Chronic Pain
3
2022
254
0.530
 Why?
Female
49
2024
68518
0.520
 Why?
Computer Simulation
4
2020
941
0.510
 Why?
Terminology as Topic
1
2017
200
0.510
 Why?
Opioid-Related Disorders
1
2023
494
0.490
 Why?
Delivery of Health Care
2
2022
894
0.490
 Why?
Cross-Over Studies
1
2017
513
0.480
 Why?
Diabetes Mellitus
3
2024
1004
0.480
 Why?
Healthcare Common Procedure Coding System
1
2014
1
0.480
 Why?
Risk Factors
23
2024
9769
0.470
 Why?
Research Design
3
2020
1040
0.460
 Why?
Insurance, Pharmaceutical Services
2
2011
23
0.450
 Why?
Adipokines
3
2022
46
0.450
 Why?
Cytokines
5
2024
1987
0.440
 Why?
Models, Statistical
2
2017
626
0.430
 Why?
Ambulatory Care
2
2014
506
0.430
 Why?
Narcotics
1
2013
47
0.420
 Why?
Hospitalization
5
2021
2077
0.420
 Why?
Emergency Service, Hospital
3
2023
1973
0.400
 Why?
Utah
7
2013
65
0.400
 Why?
Comparative Effectiveness Research
1
2013
151
0.400
 Why?
Potassium
2
2023
138
0.400
 Why?
Drug Prescriptions
2
2013
251
0.390
 Why?
Remission Induction
3
2022
271
0.390
 Why?
Pharmaceutical Preparations
3
2022
170
0.380
 Why?
Medicine
1
2013
117
0.380
 Why?
Time Factors
11
2021
6518
0.380
 Why?
Decision Support Systems, Clinical
2
2012
206
0.370
 Why?
Health Services Accessibility
2
2019
897
0.370
 Why?
Proportional Hazards Models
8
2022
1210
0.370
 Why?
Drug Overdose
2
2012
333
0.370
 Why?
Carpal Bones
2
2021
14
0.360
 Why?
Inflammatory Bowel Diseases
1
2015
312
0.350
 Why?
Disease Progression
2
2018
2613
0.350
 Why?
Cardiovascular Diseases
8
2023
2024
0.350
 Why?
Retrospective Studies
18
2023
14571
0.340
 Why?
Potentially Inappropriate Medication List
2
2020
16
0.330
 Why?
Practice Guidelines as Topic
2
2019
1493
0.330
 Why?
Adiponectin
4
2024
234
0.330
 Why?
Quality Indicators, Health Care
1
2012
297
0.320
 Why?
C-Reactive Protein
4
2021
397
0.320
 Why?
Aged, 80 and over
13
2021
7066
0.310
 Why?
Risk Assessment
10
2021
3260
0.300
 Why?
Kaplan-Meier Estimate
3
2021
864
0.300
 Why?
Body Mass Index
6
2018
2266
0.300
 Why?
Antibodies, Monoclonal
1
2014
1359
0.290
 Why?
Incidence
9
2024
2635
0.290
 Why?
Prospective Studies
9
2024
7079
0.290
 Why?
Pneumonia, Bacterial
2
2020
109
0.280
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1275
0.280
 Why?
ROC Curve
3
2019
502
0.280
 Why?
International Classification of Diseases
4
2023
124
0.270
 Why?
Multimorbidity
2
2023
46
0.260
 Why?
Managed Care Programs
1
2007
133
0.250
 Why?
Predictive Value of Tests
4
2020
1943
0.250
 Why?
Propensity Score
3
2020
265
0.250
 Why?
Arthrodesis
3
2021
111
0.250
 Why?
Drug Utilization
2
2018
167
0.240
 Why?
Drug Therapy, Combination
2
2019
1013
0.240
 Why?
Patient Admission
1
2007
184
0.240
 Why?
Embryo, Nonmammalian
2
2005
167
0.240
 Why?
Adult
16
2022
35513
0.230
 Why?
Gene Targeting
1
2004
82
0.230
 Why?
Alarmins
1
2024
24
0.230
 Why?
Data Mining
3
2023
109
0.230
 Why?
Interleukin-33
1
2024
49
0.220
 Why?
Regression Analysis
3
2018
984
0.220
 Why?
Embryo, Mammalian
1
2004
226
0.220
 Why?
Wrist
2
2021
52
0.220
 Why?
Neoplasms
5
2023
2475
0.210
 Why?
Wrist Joint
2
2021
63
0.210
 Why?
Poisson Distribution
2
2017
76
0.210
 Why?
Weight Loss
2
2018
724
0.210
 Why?
Follow-Up Studies
7
2021
4915
0.200
 Why?
Stroke
2
2021
1067
0.200
 Why?
Diclofenac
1
2022
14
0.200
 Why?
Rheumatic Diseases
1
2023
69
0.200
 Why?
Comorbidity
4
2023
1547
0.200
 Why?
Blood Sedimentation
2
2019
34
0.200
 Why?
Chemokines
2
2021
222
0.200
 Why?
Research Report
1
2022
73
0.190
 Why?
Confidence Intervals
2
2016
319
0.190
 Why?
Genetic Testing
1
2004
427
0.190
 Why?
Polymerase Chain Reaction
1
2004
1021
0.190
 Why?
Linear Models
3
2018
816
0.180
 Why?
Waldenstrom Macroglobulinemia
1
2021
11
0.180
 Why?
Multivariate Analysis
5
2018
1496
0.180
 Why?
Hospitals, Veterans
3
2018
257
0.180
 Why?
Maintenance Chemotherapy
1
2020
22
0.180
 Why?
Prescription Drugs
2
2012
116
0.170
 Why?
Cyclophosphamide
2
2021
232
0.170
 Why?
Prosthesis-Related Infections
1
2021
75
0.170
 Why?
Arthritis, Infectious
1
2021
59
0.170
 Why?
Stem Cells
1
2004
579
0.170
 Why?
Pneumonia, Staphylococcal
1
2020
20
0.170
 Why?
SEER Program
1
2020
206
0.160
 Why?
Neoplasm Grading
1
2020
284
0.160
 Why?
Transferrin
1
2019
42
0.160
 Why?
Bipolar Disorder
1
2021
233
0.160
 Why?
Ferritins
1
2019
58
0.160
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
113
0.160
 Why?
Inappropriate Prescribing
1
2019
53
0.160
 Why?
Arthroplasty, Replacement, Hip
1
2021
135
0.150
 Why?
Ranolazine
1
2018
25
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Geriatrics
1
2019
80
0.150
 Why?
Drug Monitoring
2
2012
184
0.150
 Why?
Area Under Curve
1
2019
282
0.150
 Why?
Coronary Artery Disease
2
2022
678
0.150
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
212
0.150
 Why?
Calcium Channel Blockers
1
2018
124
0.150
 Why?
Osteoarthritis
1
2020
181
0.150
 Why?
Rheumatologists
1
2017
16
0.150
 Why?
Professional Practice Location
1
2017
29
0.140
 Why?
Brain Ischemia
1
2021
306
0.140
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
111
0.140
 Why?
Longitudinal Studies
4
2023
2716
0.140
 Why?
Heart Failure
2
2021
2158
0.140
 Why?
Random Allocation
1
2018
346
0.140
 Why?
Sacroiliitis
1
2017
6
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
81
0.140
 Why?
Feasibility Studies
2
2020
862
0.140
 Why?
Communication
1
2023
840
0.140
 Why?
Obesity, Abdominal
1
2017
47
0.140
 Why?
Population Surveillance
2
2012
428
0.140
 Why?
Protease Inhibitors
1
2018
104
0.140
 Why?
Recovery of Function
1
2021
648
0.140
 Why?
Neoplasm Metastasis
1
2019
616
0.140
 Why?
Leptin
3
2022
218
0.140
 Why?
Bias
3
2013
195
0.140
 Why?
Data Accuracy
1
2017
59
0.140
 Why?
Disability Evaluation
1
2018
291
0.140
 Why?
Precision Medicine
1
2020
384
0.130
 Why?
Travel
1
2017
121
0.130
 Why?
HIV Integrase Inhibitors
1
2018
71
0.130
 Why?
Prognosis
3
2020
3788
0.130
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
73
0.130
 Why?
Risk Management
2
2007
90
0.130
 Why?
Neoplasm Staging
1
2020
1293
0.130
 Why?
Forecasting
1
2018
358
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
133
0.130
 Why?
Arthroplasty, Replacement, Knee
1
2021
300
0.130
 Why?
Anti-Inflammatory Agents
2
2018
471
0.130
 Why?
Pain
1
2022
760
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
319
0.130
 Why?
Antimicrobial Stewardship
1
2018
99
0.130
 Why?
Cross-Sectional Studies
6
2024
5070
0.130
 Why?
Cyclosporine
1
2016
169
0.130
 Why?
Hypertension
2
2018
1243
0.130
 Why?
Fees, Pharmaceutical
1
2015
13
0.130
 Why?
Drug Administration Routes
1
2015
38
0.130
 Why?
Observational Studies as Topic
1
2016
109
0.120
 Why?
Anti-Infective Agents
1
2018
226
0.120
 Why?
Anti-Retroviral Agents
1
2018
230
0.120
 Why?
Hospital Mortality
1
2020
844
0.120
 Why?
Cause of Death
4
2023
393
0.120
 Why?
Cross Infection
1
2017
196
0.120
 Why?
Pseudomonas Infections
1
2017
213
0.120
 Why?
Health Care Costs
1
2018
395
0.120
 Why?
Logistic Models
2
2018
1979
0.120
 Why?
Recombination, Genetic
3
2005
189
0.120
 Why?
Obesity
2
2018
2863
0.120
 Why?
Suicide
1
2021
587
0.120
 Why?
Inflammation Mediators
1
2017
500
0.110
 Why?
Drug Administration Schedule
1
2016
758
0.110
 Why?
Quality Improvement
1
2022
1099
0.110
 Why?
Glucocorticoids
1
2018
575
0.110
 Why?
Guideline Adherence
1
2018
525
0.110
 Why?
Health Expenditures
1
2015
185
0.110
 Why?
Infusions, Intravenous
1
2014
385
0.110
 Why?
Prednisone
3
2021
236
0.110
 Why?
Telemedicine
1
2022
783
0.110
 Why?
Causality
1
2013
115
0.100
 Why?
HIV Infections
2
2018
2715
0.100
 Why?
Integrases
3
2005
118
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
36
0.100
 Why?
Mortality
1
2015
308
0.100
 Why?
Adiposity
1
2017
505
0.100
 Why?
Socioeconomic Factors
2
2018
1210
0.100
 Why?
Pneumonia
1
2018
599
0.100
 Why?
Root Cause Analysis
1
2012
8
0.100
 Why?
Feedback
2
2023
159
0.100
 Why?
Education, Medical, Continuing
1
2013
124
0.100
 Why?
Prescription Drug Misuse
1
2012
42
0.100
 Why?
Florida
1
2012
93
0.100
 Why?
Occupational Injuries
1
2012
45
0.100
 Why?
Lung Neoplasms
2
2022
2329
0.100
 Why?
Lung Diseases
1
2018
723
0.100
 Why?
HIV-1
1
2018
842
0.090
 Why?
Health Personnel
1
2017
649
0.090
 Why?
Outpatients
1
2014
367
0.090
 Why?
Narration
1
2012
56
0.090
 Why?
Internal Medicine
1
2013
246
0.090
 Why?
Adolescent
5
2015
20302
0.090
 Why?
Antineoplastic Agents
1
2022
2060
0.090
 Why?
Osteoporotic Fractures
1
2012
57
0.090
 Why?
Risk
1
2013
856
0.090
 Why?
Reproducibility of Results
2
2016
3033
0.090
 Why?
Dose-Response Relationship, Drug
1
2014
1945
0.080
 Why?
Substance-Related Disorders
2
2023
1013
0.080
 Why?
Anti-Bacterial Agents
1
2020
1671
0.080
 Why?
Young Adult
3
2015
12389
0.080
 Why?
Blood Pressure
2
2018
1735
0.080
 Why?
Pattern Recognition, Automated
1
2008
72
0.070
 Why?
Sex Factors
3
2021
1953
0.070
 Why?
Catheter-Related Infections
1
2008
68
0.070
 Why?
Diagnosis, Computer-Assisted
1
2008
87
0.070
 Why?
Hospital Records
1
2007
11
0.070
 Why?
Cost Sharing
1
2007
15
0.070
 Why?
Financing, Personal
1
2007
26
0.070
 Why?
Referral and Consultation
1
2013
732
0.070
 Why?
Antihypertensive Agents
1
2011
490
0.070
 Why?
Biomarkers
3
2024
3896
0.070
 Why?
Nonlinear Dynamics
1
2007
88
0.070
 Why?
Machine Learning
2
2022
447
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
358
0.070
 Why?
Insulin-Like Growth Factor I
2
1999
307
0.070
 Why?
Viral Proteins
2
1999
321
0.070
 Why?
Primary Health Care
2
2013
1641
0.060
 Why?
Artificial Intelligence
1
2008
248
0.060
 Why?
Drug Interactions
1
2007
360
0.060
 Why?
Respiratory Tract Diseases
2
2017
150
0.060
 Why?
Models, Theoretical
1
2008
546
0.060
 Why?
Blotting, Southern
1
2004
68
0.060
 Why?
Health Services Research
1
2007
389
0.060
 Why?
Chronic Disease
2
2022
1707
0.060
 Why?
Data Collection
1
2007
650
0.060
 Why?
Mass Screening
1
2012
1159
0.060
 Why?
Mental Disorders
1
2012
1010
0.060
 Why?
Interleukin-17
1
2024
107
0.050
 Why?
Myocardial Infarction
1
2011
1014
0.050
 Why?
Health Status
2
2018
751
0.050
 Why?
Vital Capacity
1
2023
291
0.050
 Why?
Acetazolamide
1
2022
24
0.050
 Why?
Odds Ratio
2
2018
1025
0.050
 Why?
Telomere Shortening
1
2022
19
0.050
 Why?
Antimanic Agents
1
2021
18
0.050
 Why?
Length of Stay
1
2007
1124
0.050
 Why?
Medicare
1
2007
724
0.050
 Why?
Lithium
1
2021
37
0.050
 Why?
Valproic Acid
1
2021
47
0.050
 Why?
Chlorambucil
1
2021
9
0.050
 Why?
Medication Therapy Management
1
2022
74
0.050
 Why?
Bendamustine Hydrochloride
1
2021
11
0.050
 Why?
Vidarabine
1
2021
30
0.050
 Why?
Bortezomib
1
2021
45
0.050
 Why?
Patient Discharge
2
2023
857
0.050
 Why?
Zebrafish
1
2005
464
0.040
 Why?
Pulmonologists
1
2020
15
0.040
 Why?
Data Display
1
2020
20
0.040
 Why?
Cerebrovascular Circulation
1
2022
221
0.040
 Why?
Vincristine
1
2021
110
0.040
 Why?
Quality Control
1
2020
156
0.040
 Why?
Computed Tomography Angiography
1
2021
115
0.040
 Why?
Magnetic Resonance Imaging
2
2022
3383
0.040
 Why?
Telomere
1
2022
226
0.040
 Why?
User-Computer Interface
1
2020
148
0.040
 Why?
Bone Marrow Transplantation
1
2020
268
0.040
 Why?
Embryonic and Fetal Development
1
1999
94
0.040
 Why?
Pharmacists
1
2022
264
0.040
 Why?
Range of Motion, Articular
1
2021
388
0.040
 Why?
Doxorubicin
1
2021
322
0.040
 Why?
Piperidines
1
2021
190
0.040
 Why?
Magnetic Resonance Angiography
1
2021
237
0.040
 Why?
Adenine
1
2021
255
0.040
 Why?
Dexamethasone
1
2021
340
0.040
 Why?
Time-to-Treatment
1
2019
180
0.040
 Why?
Gene Dosage
1
1998
142
0.040
 Why?
Patient Satisfaction
1
2022
647
0.040
 Why?
Infant Mortality
1
1998
104
0.040
 Why?
Cost-Benefit Analysis
1
2020
582
0.040
 Why?
Reoperation
1
2020
560
0.040
 Why?
Methicillin Resistance
1
2017
17
0.040
 Why?
Recurrence
1
2020
1003
0.040
 Why?
Gene Expression Regulation, Developmental
2
1999
818
0.040
 Why?
HIV Integrase
1
2018
71
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Cardiovascular Agents
1
2018
152
0.030
 Why?
Absorptiometry, Photon
1
2017
251
0.030
 Why?
Critical Illness
1
2022
736
0.030
 Why?
Isoxazoles
1
2016
54
0.030
 Why?
Thinness
1
2016
90
0.030
 Why?
Nutrition Surveys
1
2017
262
0.030
 Why?
Body Weight
2
2016
932
0.030
 Why?
Viral Load
1
2018
450
0.030
 Why?
Rheumatoid Factor
1
2016
168
0.030
 Why?
Community-Acquired Infections
1
2017
152
0.030
 Why?
Lymphoma
1
2016
194
0.030
 Why?
Survival Analysis
1
2018
1265
0.030
 Why?
Analysis of Variance
1
2018
1271
0.030
 Why?
Peptides, Cyclic
1
2016
255
0.030
 Why?
Surveys and Questionnaires
2
2020
5377
0.030
 Why?
Leukemia
1
2016
229
0.030
 Why?
Quality of Health Care
1
2018
608
0.030
 Why?
Age Factors
1
2021
3120
0.030
 Why?
Life Style
1
2016
460
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2541
0.030
 Why?
Workers' Compensation
1
2012
26
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1573
0.020
 Why?
Inflammation
1
2022
2668
0.020
 Why?
Coroners and Medical Examiners
1
2011
7
0.020
 Why?
Death Certificates
1
2011
32
0.020
 Why?
Sampling Studies
1
2011
96
0.020
 Why?
Brain
1
2022
2628
0.020
 Why?
Smoking
1
2016
1466
0.020
 Why?
Prostatic Neoplasms
1
2016
1013
0.020
 Why?
Pancreatic Neoplasms
1
2016
878
0.020
 Why?
Medical Assistance
1
2007
12
0.020
 Why?
Models, Econometric
1
2007
34
0.020
 Why?
Quality of Life
1
2019
2694
0.020
 Why?
Psychoses, Substance-Induced
1
2007
14
0.020
 Why?
Deductibles and Coinsurance
1
2007
11
0.020
 Why?
Eligibility Determination
1
2007
63
0.020
 Why?
Inpatients
1
2011
464
0.020
 Why?
Child
1
2007
20806
0.020
 Why?
Evidence-Based Medicine
1
2011
718
0.020
 Why?
Costs and Cost Analysis
1
2007
209
0.020
 Why?
Delirium
1
2007
77
0.020
 Why?
Insurance Coverage
1
2007
222
0.020
 Why?
Blood Coagulation Disorders
1
2007
162
0.020
 Why?
beta-Galactosidase
1
2005
75
0.020
 Why?
HSP70 Heat-Shock Proteins
1
2005
67
0.010
 Why?
Mosaicism
1
2005
71
0.010
 Why?
Genes, Reporter
1
2005
266
0.010
 Why?
Animals, Genetically Modified
1
2005
232
0.010
 Why?
Sensitivity and Specificity
1
2008
1825
0.010
 Why?
Mice, Transgenic
2
1999
2079
0.010
 Why?
Case-Control Studies
1
2011
3342
0.010
 Why?
Hemorrhage
1
2007
645
0.010
 Why?
Recombinant Fusion Proteins
1
2005
634
0.010
 Why?
Liver
2
1999
1833
0.010
 Why?
Growth Disorders
1
1998
80
0.010
 Why?
Animals
3
2005
34600
0.010
 Why?
Mice
2
1999
16644
0.010
 Why?
RNA, Messenger
1
1998
2676
0.010
 Why?
Infant, Newborn
1
1998
5739
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (390) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)